IL32 and autoimmune disease: Understanding the contribution of MIAT in the regulation of Th17 response may offer new approaches to mitigate the inflammation in RA given its connection with IL-17 and its co-regulation with IL-32, another cytokine increasingly associated with autoimmune diseases, including RA.